氯雷他定联合玉屏风散加味治疗慢性荨麻疹临床疗效观察  

Observation of Therapeutic Effect of Loratadine Combined Modified Yupingfengsan on Chronic Urticaria

作　　者：谢水根[1] 王尚昆[1] 吴永生[1] 

机构地区：[1]永丰县人民医院,江西永丰331500

出　　处：《中西医结合研究》2011年第6期288-290,共3页Research of Integrated Traditional Chinese and Western Medicine

摘　　要：目的观察氯雷他定联合玉屏风散治疗慢性荨麻疹的疗效。方法将荨麻疹患者130例随机分为治疗组70例和对照组60例。治疗组口服玉屏风散,1剂/日,氯雷他定10mg,1次/日;对照组口服氯雷他定10mg,1次/日;两组均分别于用药后第7、14、28天观察疗效和不良反应。结果治疗组与对照组的有效率分别为91.43%和66.67%,两组比较差异有统计学意义(P<0.05);两组均未见明显不良反应。结论玉屏风散联合氯雷他定治疗慢性荨麻疹疗效显著。Objective To observe the therapeutic effect of loratadine combined modified Yupingfengsan on chronic urticaria. Methods 130 patients with chronic urticaria were divieded into two groups randamly, 70 patients in the treatment group were given modified Yupingfengsan and loratadine, 60 patients in the control group were only given loratadine. Observe the efficacy and adverse reactions after 7 days, 14 days,and 28 days respectively. Results The effective rates of treatment group and control group were 91.43% vs 66. 67% ,and there was significant difference between the two groups（P〈0.05）. In addition,mild adverse reactions were found in two groups. Conclusion Loratadine combined modified Yupingfengsan were effective for the treatment of chronic urticaria.

关 键 词：玉屏风散 氯雷他定 慢性荨麻疹 

分 类 号：R758.24[医药卫生—皮肤病学与性病学]